Nanoparticles Show Promise in Targeting Tumor Blood Vessels for Cancer Treatment

Nanoparticles may hold the key to effective treatment of cancer by targeting the VEGF/VEGFR pathway, which plays a crucial role in regulating angiogenesis, the formation of new blood vessels. Researchers at the Poznan University of Medical Sciences have conducted a comprehensive review of nanoparticles designed for selective targeting of tumor vasculature, highlighting the challenges faced by anti-angiogenic cancer therapies. The study explores the application of inorganic, lipid, and polymeric nanoparticles in delivering drugs while minimizing systemic side effects.

Key Takeaways:

• Angiogenesis is a critical process in tumor growth and metastasis, and targeting it may lead to effective cancer treatment.
• The VEGF/VEGFR pathway plays a crucial role in regulating angiogenesis, and many anti-angiogenesis agents have been investigated for cancer treatment.
• Nanoparticles have emerged as a promising tool for effective drug delivery while minimizing systemic side effects.
• Researchers have developed a series of nanoparticles designed for selective targeting of tumor vasculature, emphasizing the challenges faced by anti-angiogenic cancer therapies.
• Drug delivery systems based on inorganic, lipid, and polymeric nanoparticles have been explored for targeting the tumor vasculature.
• Functionalized nanoparticles have been designed to precisely target proteins overexpressed on endothelial cells, tumors, or other cells in the tumor microenvironment.
• The Poznan University of Medical Sciences research team consists of Hanna Dams-Kozlowska, Chair of Medical Biotechnology, Dept. of Cancer Immunology, and other researchers, including Patryk Lorenc, Natalia Guzniczak, and Anna Florczak-Substyk.

Statistics:

• Cancer remains one of the leading causes of death worldwide.
• The formation of new blood vessels, angiogenesis, is a critical process in tumor growth.
• The VEGF/VEGFR pathway plays a crucial role in regulating angiogenesis.
• Many anti-angiogenesis agents have been investigated for cancer treatment.
• 186:118038 is the ID of the research article published in Biomedicine & Pharmacotherapy.
• Biomedicine & Pharmacotherapy is the journal where the research article was published.

Sources:

• Application of nanoparticles to target tumor blood vessels as a promising cancer treatment strategy. Biomedicine & Pharmacotherapy, 2025;186:118038.
• Poznan University of Medical Sciences Reports Findings in Cancer (Application of nanoparticles to target tumor blood vessels as a promising cancer treatment strategy). Nanotechnology Weekly. April 28, 2025; p 864.